esmolol has been researched along with Cardiomyopathy, Dilated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chlouverakis, G; Hamilos, MI; Kochiadakis, GE; Parthenakis, FI; Skalidis, EI; Vardas, PE | 1 |
| Dernellis, JM; Toutouzas, PK; Vyssoulis, GP; Zacharoulis, AA | 1 |
1 trial(s) available for esmolol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Angiography; Coronary Circulation; Female; Humans; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Middle Aged; Propanolamines; Pulsatile Flow | 2007 |
1 other study(ies) available for esmolol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Acute changes of left atrial distensibility in congestive heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Female; Heart Atria; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Propanolamines; Vasodilator Agents | 1998 |